Advancements in Proton Arc Therapy at Trento Center Unveiled
Revolutionizing Proton Therapy with RayStation
RaySearch Laboratories AB (publ) has introduced a groundbreaking method for treating patients at the Trento Proton Therapy Center in Italy. This innovative technique utilizes discrete proton arc optimization through RayStation, combined with established delivery methods and treatment processes, marking a significant advancement in the field of radiotherapy.
The Mechanics of Proton Arc Therapy
Proton therapy is recognized as a cutting-edge approach to radiotherapy. It employs highly focused energy deposition that can be meticulously directed at tumors. Traditionally, these treatments have relied upon a limited number of delivery angles. However, with discrete proton arc therapy, treatment delivery expands to encompass a range of 20 to 30 angles. This method could potentially reduce treatment times substantially once enhanced treatment machines are established, while also allowing for seamless conversion of arc plans to standard plans implementable with existing proton machines.
Research Insights from Trento Proton Therapy Center
The Medical Physics team at the Trento Proton Therapy Center has conducted an extensive study comparing their established planning techniques for patients with head and neck cancers against proton arc methods. Their findings indicated that using proton arcs resulted in significant reductions in radiation dosage outside the tumor volume, corroborating earlier preclinical studies. Moving forward, the team undertook quality assurance tests with a specialized detector designed for arc therapy to evaluate how this technique would influence clinical operations, including treatment duration. Their conclusion confirmed that discrete proton arc therapy is viable within their existing treatment framework from IBA, and patient treatments have officially commenced.
Voices from the Trento Proton Therapy Center
Frank Lohr, Medical Chair, and Francesco Fracchiolla, Project Lead Arc Therapy at the center, expressed enthusiasm for the advancements offered by this technology. They stated, "Similar to how VMAT has transformed traditional photon radiotherapy, proton arc treatments stand to unlock remarkable benefits for proton therapy across various clinical applications. Our fruitful collaboration with radiation oncologists and medical physicists, alongside RaySearch, has paved the way for this innovative delivery method."
Future Directions and Commitment
Johan Löf, the founder and CEO of RaySearch, emphasized the significance of implementing proton arc treatments as a pivotal achievement within the realm of proton therapy. He acknowledged the dedication of the Trento Proton Therapy Center team in integrating this new technique into their operational framework. Löf expressed pride in RaySearch's vital contribution to advancing proton arc therapy through the development of sophisticated optimization algorithms and planning tools.
CONTACT:
For further details, please reach out to:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
Frequently Asked Questions
What is proton arc therapy?
Proton arc therapy is an advanced form of radiotherapy that allows treatment from multiple directions, improving the precision of tumor targeting.
How does RayStation contribute to proton therapy?
RayStation facilitates discrete proton arc optimization, enabling healthcare providers to streamline treatment workflows and enhance patient care.
What advantages does discrete proton arc therapy offer?
The technique provides more efficient treatment times, significant dose reductions outside the tumor volume, and adaptability for various proton machines.
Who is involved in the development of this treatment?
A collaborative team of radiation oncologists, medical physicists, and specialists from RaySearch Laboratories spearheads the development and implementation of proton arc therapy.
Where is this therapy currently being used?
The Trento Proton Therapy Center in Italy is among the first to apply discrete proton arc therapy in clinical settings.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. If any of the material offered here is inaccurate, please contact us for corrections.